NXS – Next Science Limited
Next Science's objective is to commercialise its proprietary technology for the treatment of biofilm protected bacteria, primarily in the area of human health and with potential applications in animal health and industrial segments.
The Company's proprietary Xbio technology is a non-toxic technology with proven efficacy in eradicating biofilm and biofilm protected bacteria. Xbio has been validated by extensive clinical testing, multiple FDA clearances and more than 70,000 patient treatments…
